SCHEMBL15535932

SCHEMBL15535932

O=C(O)N1CCC(CC(O)c2ccc(Cl)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.44
GMNN O75496 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
THPO P40225 1/20 0.44
MTOR P42345 1/20 0.44
BLM P54132 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2B Q13224 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALOX5 P09917 1/20 0.44
SLC6A2 P23975 2/20 0.43
SLC6A3 Q01959 2/20 0.43
SLC6A4 P31645 1/20 0.41
MAPT P10636 2/20 0.41
CNR1 P21554 1/20 0.41
GPX4 P36969 1/20 0.40
SLC6A9 P48067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085986 0.87 CYP2D6 (0.49) TSHRNFKB1
SCHEMBL14782621 0.86 SLC18A3 (0.45) NPSR1
SCHEMBL868087 0.81 AOC3 (0.46) TP53GMNNCYP3A4ALOX15TSHR
SCHEMBL15535953 0.81 ALDH1A1 (0.52) NPSR1MAPTCNR1
SCHEMBL15536002 0.81 FPR2 (0.47) CYP3A4TSHRMAPT
SCHEMBL14783190 0.80 DHODH (0.50) TSHRGRIN2B
SCHEMBL10633563 0.77 SLC6A2 (0.54) TP53GMNNCYP3A4ALOX15TSHR
SCHEMBL4959434 0.76 ALDH1A1 (0.59)
SCHEMBL13391312 0.74 SLC6A2 (0.46) TP53GMNNCYP3A4ALOX15TSHR
SCHEMBL20601295 0.74 KDM4E (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3218363-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED GASTROINTESTINAL DISORDERS Takeda Pharmaceutical Company Limited (JP) 2017-09-20 EP disclosed
WO-2016075457-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED GASTROINTESTINAL DISORDERS TAKEDA CAMBRIDGE LIMITED (GB) 2016-05-19 WO disclosed
EP-2855449-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed
WO-2013179024-A1 SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-12-05 WO disclosed